About Mercy Women's Oncology
Clinical Trials at Mercy Women's Oncology
During the past decade, Mercy Women's Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Women's Oncology"
#1 collaborator was "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Mercy Women's Oncology
According to Clinical.Site data, the most researched conditions in "Mercy Women's Oncology" are
"Ovarian Cancer" (2 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Primary Peritoneal Carcinoma" (1 trials). Many other conditions were trialed in "Mercy Women's Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Women's Oncology
Most popular intervention types in "Mercy Women's Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (1 trials), "Mirvetuximab soravtansine" (1 trials), "Paclitaxel" (1 trials), "Pegylated liposomal doxorubicin" (1 trials) and "Topotecan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Women's Oncology
The vast majority of trials in "Mercy Women's Oncology" are
2 trials for "Female" genders.
Clinical Trials Status at Mercy Women's Oncology
Currently, there are NaN active trials in "Mercy Women's Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Mercy Women's Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Women's Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".